Psychiatric Times

Premier online and print content, written by and for #mentalhealth care physicians and professionals. Questions? Email: [email protected].

[Psychiatric Times @PsychTimes]

The FDA has issued a Complete Response Letter for CTx-1301, a novel formulation of dexmethylphenidate for treatment of ADHD. https://t.co/9FOOvnkkgq

[Psychiatric Times @PsychTimes]

Our June theme: Special Populations.

We want to hear your clinical insights! Submit to our content series ⬇️ https://t.co/oprimfALME

[Psychiatric Times @PsychTimes]

This Memorial Day, Psychiatric Times honors the brave individuals who made the ultimate sacrifice in service to our country. We remember their courage, reflect on their legacy, and express gratitude to all who have served.

[Psychiatric Times @PsychTimes]

🎙️🧐💊 This week's "Brain Trust" episode is now live!

Guest Michael Gitlin, MD, shares insights on the complex psychopharmacology of personality disorders: https://t.co/dsCNeXnTcb

[Psychiatric Times @PsychTimes]

Antipsychotic medications remain the most effective intervention for reducing psychotic symptoms and preventing relapse. Yet medication alone is often insufficient. Psychotherapy can play an important role in relapse prevention and long-term recovery. https://t.co/W6qzkv8FJ6

[Psychiatric Times @PsychTimes]

The HHS has released the Surgeon General’s “Warning on the Harms of Screen Use," which aims to raise national awareness about the growing risks associated with excessive and harmful screen use among youth. https://t.co/Ivp1QinFSw

[Psychiatric Times @PsychTimes]

Need new reading material? The entire May 2026 issue of Psychiatric Times is now live on our website. Read it here: https://t.co/BhrCIaTmus

[Psychiatric Times @PsychTimes]

The latest focus on psychedelic use for mood disorders and continued research into neuromodulation holds much potential. #APAAM26 https://t.co/sdeunG7vtk

[Psychiatric Times @PsychTimes]

Ketamine-assisted psychotherapy may have a practical advantage over psilocybin, MDMA, and LSD-assisted protocols, which typically require 6 to 10 hours per session, compared with approximately 2 hours for ketamine-assisted psychotherapy. #APAAM26 https://t.co/CnrHlvEYqT

[Psychiatric Times @PsychTimes]

Behavioral addictions extend beyond traditional internet overuse and may include compulsive gaming, extreme online gambling, and even maladaptive exercise behaviors shaped by social media culture, shared Hector Colon-Rivera, MD. #APAAM26 https://t.co/nt2jjwNUW5

[Psychiatric Times @PsychTimes]

Christoph Correll, MD, presented efficacy and real-world data on olanzapine-samidorphan for schizophrenia and bipolar disorder at #APAAM26. He found that it keeps olanzapine efficacy yet limits weight gain, improves negative symptoms, and cuts ER visits. https://t.co/KtkDV2kd6m

[Psychiatric Times @PsychTimes]

Synendos Therapeutics has initiated dosing in a phase 2 trial of SYT-510, a first-in-class endocannabinoid modulator, aiming to ease generalized anxiety disorder symptoms with improved safety and adherence. @synendos
https://t.co/J7IuDAs5Xi

[Psychiatric Times @PsychTimes]

Adult patients with ADHD rarely self-identify their core symptoms. Instead, they typically present with anxiety, depression, and general distress—requiring the clinician to actively probe for ADHD features beyond the presenting complaint. #APAAM26
https://t.co/swOGR9ZjDH

[Psychiatric Times @PsychTimes]

Patients with preexisting severe mental illness, including schizophrenia and bipolar disorder, who subsequently develop cancer face significant disparities in cancer screening and access to care, shared Michelle Riba, MD, MS. #APAAM26
https://t.co/wlnjxcqKU2

[Psychiatric Times @PsychTimes]

Childbirth-related PTSD: frequently overlooked and underdiagnosed in postpartum care. Amanda Koire shares more on the clinical pattern she noticed. #APAAM26
https://t.co/psg5we0vvB

[Psychiatric Times @PsychTimes]

How can we spot digital behavioral addiction?

Watch this short video to learn more and keep your eyes peeled for our upcoming June cover story 👀

#APAAM26
https://t.co/DO8td88hQX

[Psychiatric Times @PsychTimes]

When having conversations with older adult patients about their sexual wellness, Anita Clayton shared that it's critical to:
1. Have an open dialogue.
2. Do not make assumptions about their preferences or activity.

#APAAM26
https://t.co/rMqTMrzTrc

[Psychiatric Times @PsychTimes]

Join us this December for the 2026 Southern Florida Psychiatry Conference in Aventura, Florida, where experts will tackle today’s most pressing challenges in mental health care.

⏳ Early bird savings end August 31—secure your spot now: https://t.co/btostaUZsZ

[Psychiatric Times @PsychTimes]

New data from the largest tardive dyskinesia (TD) study to date highlights a significant gap in diagnosing TD in patients with comorbid mood disorders: young adults with mood disorders face high TD burden yet low diagnosis rates. https://t.co/TJRDts5I4M

[Psychiatric Times @PsychTimes]

XPro1595 showed directionally consistent benefit across cognitive, global, functional, behavioral, and biomarker endpoints over 24 weeks in an Alzheimer disease with inflammation subgroup, with no amyloid-related imaging abnormalities. https://t.co/nJ6kkWsJWG